Alterity Therapeutics’ Finance News Network Presentation

On June 6 2019, Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, participated in the Finance News Network Investor event in Sydney. The presentation included the company’s lead drug candidate, the potential applications for the drug and the breadth of the market. The presentation is now available to view here.